Skip Nav Destination
Issues
15 September 2004
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Cancer Research
Table of Contents
Advances in Brief
Molecular Biology, Pathobiology, and Genetics
α2HS-glycoprotein, an Antagonist of Transforming Growth Factor β In vivo, Inhibits Intestinal Tumor Progression
Carol J. Swallow; Emily A. Partridge; Jennifer C. Macmillan; Tania Tajirian; Gianni M. DiGuglielmo; Kazy Hay; Melanie Szweras; Willi Jahnen-Dechent; Jeff L. Wrana; Mark Redston; Steven Gallinger; James W. Dennis
Functional Characterization of the Candidate Tumor Suppressor Gene NPRL2/G21 Located in 3p21.3C
Jingfeng Li; Fuli Wang; Klas Haraldson; Alexey Protopopov; Fuh-Mei Duh; Laura Geil; Igor Kuzmin; John D. Minna; Eric Stanbridge; Eleonora Braga; Vladimir I. Kashuba; George Klein; Michael I. Lerman; Eugene R. Zabarovsky
Genomic and Expression Profiling of Chromosome 17 in Breast Cancer Reveals Complex Patterns of Alterations and Novel Candidate Genes
Béatrice Orsetti; Mélanie Nugoli; Nathalie Cervera; Laurence Lasorsa; Paul Chuchana; Lisa Ursule; Catherine Nguyen; Richard Redon; Stanislas du Manoir; Carmen Rodriguez; Charles Theillet
Tumor Cell-Specific BRCA1 and RASSF1A Hypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients
Inmaculada Ibanez de Caceres; Cristina Battagli; Manel Esteller; James G. Herman; Essel Dulaimi; Mitchell I. Edelson; Cynthia Bergman; Hormoz Ehya; Burton L. Eisenberg; Paul Cairns
Cell and Tumor Biology
Nuclear Factor-κB is an Important Modulator of the Altered Gene Expression Profile and Malignant Phenotype in Squamous Cell Carcinoma
Amy Loercher; Tin Lap Lee; Justin L. Ricker; April Howard; Joel Geoghegen; Zhong Chen; John B. Sunwoo; Raquel Sitcheran; Eric Y. Chuang; James B. Mitchell; Albert S. Baldwin, Jr.; Carter Van Waes
Retinoic Acid Increases the Expression of p53 and Proapoptotic Caspases and Sensitizes Keratinocytes to Apoptosis: A Possible Explanation for Tumor Preventive Action of Retinoids
Paul Mrass; Michael Rendl; Michael Mildner; Florian Gruber; Barbara Lengauer; Claudia Ballaun; Leopold Eckhart; Erwin Tschachler
Tumor-Microenvironment Interactions: The Fucose-Generating FX Enzyme Controls Adhesive Properties of Colorectal Cancer Cells
Adi Zipin; Mira Israeli-Amit; Tsipi Meshel; Orit Sagi-Assif; Ilana Yron; Veronica Lifshitz; Eran Bacharach; Nechama I. Smorodinsky; Ariel Many; Peter A. Czernilofsky; Donald L. Morton; Isaac P. Witz
Experimental Therapeutics, Molecular Targets, and Chemical Biology
Excellent In vivo Bystander Activity of Fludarabine Phosphate against Human Glioma Xenografts that Express the Escherichia coli Purine Nucleoside Phosphorylase Gene
Jeong S. Hong; William R. Waud; Dana N. Levasseur; Tim M. Townes; Hui Wen; Sylvia A. McPherson; Bryan A. Moore; Zsuzsa Bebok; Paula W. Allan; John A. Secrist, III; William B. Parker; Eric J. Sorscher
Increased Plasma Vascular Endothelial Growth Factor (VEGF) as a Surrogate Marker for Optimal Therapeutic Dosing of VEGF Receptor-2 Monoclonal Antibodies
Guido Bocci; Shan Man; Shane K. Green; Giulio Francia; John M. L. Ebos; Jeanne M. du Manoir; Adina Weinerman; Urban Emmenegger; Li Ma; Philip Thorpe; Andrew Davidoff; James Huber; Daniel J. Hicklin; Robert S. Kerbel
The Histone Deacetylase Inhibitor NVP-LAQ824 Inhibits Angiogenesis and Has a Greater Antitumor Effect in Combination with the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor PTK787/ZK222584
David Z. Qian; Xiaofei Wang; Sushant K. Kachhap; Yukihiko Kato; Yongfeng Wei; Lu Zhang; Peter Atadja; Roberto Pili
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib): Relationships among Protein Conformation, Inhibitor Off-Rate, and Receptor Activity in Tumor Cells
Edgar R. Wood; Anne T. Truesdale; Octerloney B. McDonald; Derek Yuan; Anne Hassell; Scott H. Dickerson; Byron Ellis; Christopher Pennisi; Earnest Horne; Karen Lackey; Krystal J. Alligood; David W. Rusnak; Tona M. Gilmer; Lisa Shewchuk
PEGylation Confers Greatly Extended Half-Life and Attenuated Immunogenicity to Recombinant Methioninase in Primates
Zhijian Yang; Junhua Wang; Quan Lu; Jinbao Xu; Yoshinao Kobayashi; Tomoaki Takakura; Akio Takimoto; Takayuji Yoshioka; Changgen Lian; Chunmei Chen; Dongdong Zhang; Ying Zhang; Shukuan Li; Xinghua Sun; Yuying Tan; Shigeo Yagi; Eugene P. Frenkel; Robert M. Hoffman
SJG-136 (NSC 694501), a Novel Rationally Designed DNA Minor Groove Interstrand Cross-Linking Agent with Potent and Broad Spectrum Antitumor Activity: Part 1: Cellular Pharmacology, In vitro and Initial In vivo Antitumor Activity
John A. Hartley; Victoria J. Spanswick; Natalie Brooks; Peter H. Clingen; Peter J. McHugh; Daniel Hochhauser; R. Barbara Pedley; Lloyd R. Kelland; Michael C. Alley; Robert Schultz; Melinda G. Hollingshead; Karen M. Schweikart; Joseph E. Tomaszewski; Edward A. Sausville; Stephen J. Gregson; Philip W. Howard; David E Thurston
SJG-136 (NSC 694501), A Novel Rationally Designed DNA Minor Groove Interstrand Cross-Linking Agent with Potent and Broad Spectrum Antitumor Activity: Part 2: Efficacy Evaluations
Michael C. Alley; Melinda G. Hollingshead; Christine M. Pacula-Cox; William R. Waud; John A. Hartley; Philip W. Howard; Stephen J. Gregson; David E. Thurston; Edward A. Sausville
Synthesis and Evaluation of Bombesin Derivatives on the Basis of Pan-Bombesin Peptides Labeled with Indium-111, Lutetium-177, and Yttrium-90 for Targeting Bombesin Receptor-Expressing Tumors
Hanwen Zhang; Jianhua Chen; Christian Waldherr; Karin Hinni; Beatrice Waser; Jean Claude Reubi; Helmut R. Maecke
Immunology
Endocrinology
Epidemiology and Prevention
Chemopreventive n-3 Polyunsaturated Fatty Acids Reprogram Genetic Signatures during Colon Cancer Initiation and Progression in the Rat
Laurie A. Davidson; Danh V. Nguyen; Regina M. Hokanson; Evelyn S. Callaway; Robert B. Isett; Nancy D. Turner; Edward R. Dougherty; Naisyin Wang; Joanne R. Lupton; Raymond J. Carroll; Robert S. Chapkin
Meeting Report
Letters to the Editor
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds